We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » German Sandoz Unit Gets Warning Over cGMP Violations
German Sandoz Unit Gets Warning Over cGMP Violations
December 6, 2011
The FDA has warned Jenahexal, a Jena, Germany-based subsidiary of Sandoz, for marketing four unapproved homeopathic injectable drugs and for cGMP violations, including inadequate aseptic procedures.